EMR2 Antibody (494025) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # FAB4894I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 549
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 494025
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human EMR2
Gln24-Asn823
Accession # AAI27006
Gln24-Asn823
Accession # AAI27006
Specificity
Detects human EMR2 in EMR2-transfected cells but not in the parental cell line.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for EMR2 Antibody (494025) [Janelia Fluor® 549]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: EMR2
Long Name
EGF-like Module Containing, Mucin-like, Hormone Receptor-like 2
Alternate Names
CD312
Gene Symbol
EMR2
Additional EMR2 Products
Product Documents for EMR2 Antibody (494025) [Janelia Fluor® 549]
Product Specific Notices for EMR2 Antibody (494025) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...